13F Holdings
中文EN

MASS 908 Devices Inc.

Laboratory Analytical Instruments · Nasdaq · SEC CIK 1555279 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY23.7%
TTM net income YoY-487.1%
TTM EPS YoY-384.6%
Revenue 3-yr CAGR11.5%
Net income 3-yr CAGR—

Margins

Gross margin52.3%
Operating margin-42.7%
Net margin-36.9%
FCF margin4.0%
EBITDA margin-34.9%

Returns

ROE-17.0%
ROA-12.4%
ROIC (approx.)-27.8%
Asset turnover0.34x

Leverage & solvency

Liabilities / assets24.9%
Debt / equity0.00x
Current ratio5.43x
Interest coverage—

Cash quality & payout

Operating cash flow / net income-0.12x
Accruals ratio-13.9%
Payout ratio—
Capex / revenue0.4%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31FY20232023-12-31FY20222022-12-31FY20212021-12-31
Income statement
Revenue$56.20M$47.75M$50.23M$46.85M$42.21M
Cost of revenue$27.77M$23.25M$24.91M$20.83M$18.97M
Gross profit$28.42M$24.50M$25.32M$26.02M$23.23M
R&D expense$15.57M$14.99M$21.90M$17.53M$13.07M
SG&A expense$38.53M$39.46M$46.07M$43.88M$32.23M
Operating income-$39.42M-$57.39M-$42.76M-$35.38M-$22.07M
Interest expense——$201,000$129,000$486,000
Pretax income-$33.34M-$53.14M-$36.61M-$33.56M—
Income tax-$66,000-$282,000-$211,000$0—
Net income$19.49M-$72.21M-$36.40M-$33.56M-$22.17M
EBITDA-$34.96M-$52.71M-$40.37M-$33.77M-$21.14M
EPS (basic)0.54-2.12-1.13-1.07-0.79
EPS (diluted)0.54-2.12-1.13-1.07-0.79
Weighted avg. shares (diluted)35.90M34.08M32.24M31.49M27.96M
Balance sheet
Cash & equivalents$70.52M$44.20M$121.21M$188.59M$224.13M
Short-term investments$42.45M$25.57M$24.64M$0—
Receivables$11.33M$8.85M$8.99M$10.03M$16.38M
Inventory$12.99M$10.89M$14.94M$12.51M$7.92M
Current assets$144.56M$103.06M$173.79M$215.63M$252.89M
PP&E, net$4.23M$1.59M$3.34M$3.08M$1.60M
Goodwill$0$0$10.37M$10.05M—
Intangibles$36.41M$38.68M$7.86M$8.49M—
Total assets$190.07M$159.48M$202.98M$242.59M$260.91M
Current liabilities$34.06M$25.15M$22.55M$19.23M$14.84M
Long-term debt———$15.00M$15.00M
Total debt———$15.00M$15.00M
Total liabilities$46.37M$44.88M$37.49M$51.99M$46.30M
Shareholders' equity$143.70M$114.59M$165.49M$190.60M$214.60M
Net debt———-$173.59M-$209.13M
Shares outstanding36.32M35.10M32.52M31.86M31.08M
Cash flow statement
Operating cash flow-$23.69M-$30.25M-$25.06M-$20.93M-$29.08M
Capital expenditure$955,000$602,000$2.04M$2.04M$737,000
Free cash flow-$24.64M-$30.85M-$27.10M-$22.98M-$29.82M
Investing cash flow$50.75M-$46.32M-$26.40M-$15.81M-$737,000
Financing cash flow-$697,000-$376,000-$15.94M$1.18M$94.72M
Depreciation & amortization$4.46M$4.68M$2.38M$1.61M$925,000
Stock-based compensation$9.85M$11.76M$9.79M$7.21M$2.50M

Free plan shows the latest 5 periods; Pro shows all 6 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.